<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39363185</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1755-8794</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>BMC medical genomics</Title><ISOAbbreviation>BMC Med Genomics</ISOAbbreviation></Journal><ArticleTitle>Fragmentomics of plasma mitochondrial and nuclear DNA inform prognosis in COVID-19 patients with critical symptoms.</ArticleTitle><Pagination><StartPage>243</StartPage><MedlinePgn>243</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">243</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12920-024-02022-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The mortality rate of COVID-19 patients with critical symptoms is reported to be 40.5%. Early identification of patients with poor progression in the critical cohort is essential to timely clinical intervention and reduction of mortality. Although older age, chronic diseases, have been recognized as risk factors for COVID-19 mortality, we still lack an accurate prediction method for every patient. This study aimed to delve into the cell-free DNA fragmentomics of critically ill patients, and develop new promising biomarkers for identifying the patients with high mortality risk.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We utilized whole genome sequencing on the plasma cell-free DNA (cfDNA) from 33 COVID-19 patients with critical symptoms, whose outcomes were classified as survival (n = 16) and death (n = 17). Mitochondrial DNA (mtDNA) abundance and fragmentomic properties of cfDNA, including size profiles, ends motif and promoter coverages were interrogated and compared between survival and death groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Significantly decreased abundance (~ 76% reduction) and dramatically shorter fragment size of cell-free mtDNA were observed in deceased patients. Likewise, the deceased patients exhibited distinct end-motif patterns of cfDNA with an enhanced preference for "CC" started motifs, which are related to the activity of nuclease DNASE1L3. Several dysregulated genes involved in the COVID-19 progression-related pathways were further inferred from promoter coverages. These informative cfDNA features enabled a high PPV of 83.3% in predicting deceased patients in the critical cohort.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The dysregulated biological processes observed in COVID-19 patients with fatal outcomes may contribute to abnormal release and modifications of plasma cfDNA. Our findings provided the feasibility of plasma cfDNA as a promising biomarker in the prognosis prediction in critically ill COVID-19 patients in clinical practice.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Haiqiang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>BGI Research, Shenzhen , Guangdong, 518083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Lingguo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>BGI Research, Shenzhen , Guangdong, 518083, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 10049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Luo</LastName><ForeName>Yuxue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>BGI Research, Shenzhen , Guangdong, 518083, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zheng</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan , Hubei, 430022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>BGI Research, Shenzhen , Guangdong, 518083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xie</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ou</LastName><ForeName>Rijing</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>BGI Research, Shenzhen , Guangdong, 518083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yilin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>BGI Research, Shenzhen , Guangdong, 518083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yeqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>BGI Research, Shenzhen , Guangdong, 518083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan , Hubei, 430022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jinjin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>BGI Research, Shenzhen , Guangdong, 518083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Ye</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>BGI Research, Shenzhen , Guangdong, 518083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Ruokai</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>BGI Research, Shenzhen , Guangdong, 518083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Wenwen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>BGI Research, Shenzhen , Guangdong, 518083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>BGI Research, Shenzhen , Guangdong, 518083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Fanjun</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China. chengfanjun001@sina.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>BGI Research, Shenzhen , Guangdong, 518083, China. jinxin@genomics.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, China. jinxin@genomics.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shenzhen Key Laboratory of Transomics Biotechnologies, BGI Research, Shenzhen, Guangdong, 518083, China. jinxin@genomics.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Genomics</MedlineTA><NlmUniqueID>101319628</NlmUniqueID><ISSNLinking>1755-8794</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004272">DNA, Mitochondrial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073888">Cell-Free Nucleic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004272" MajorTopicYN="Y">DNA, Mitochondrial</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073888" MajorTopicYN="Y">Cell-Free Nucleic Acids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">CfDNA</Keyword><Keyword MajorTopicYN="N">Prognosis prediction</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>23</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39363185</ArticleId><ArticleId IdType="pmc">PMC11451003</ArticleId><ArticleId IdType="doi">10.1186/s12920-024-02022-2</ArticleId><ArticleId IdType="pii">10.1186/s12920-024-02022-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO COVID-19 dashboard [https://covid19.who.int/] Accessed on 29 September 2024. https://tumor.informatics.jax.org/cancer_links.html.</Citation></Reference><Reference><Citation>von Stillfried S, Bülow RD, Röhrig R, Boor P, Böcker J, Schmidt J, et al. First report from the German COVID-19 autopsy registry. Lancet Reg Heal - Eur. 2022;15:100330. 10.1016/j.lanepe.2022.100330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9073019</ArticleId><ArticleId IdType="pubmed">35531493</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian XW, Yao XH, Ping YF, Yu S, Shi Y, Luo T, et al. Autopsy of COVID-19 patients in China. Nat Sci Rev. 2020;7:1414–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7313767</ArticleId><ArticleId IdType="pubmed">34192086</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507. 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel Coronavirus in Wuhan China. Lancet. 2020;395:497. 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedo A, Gonçalves N, Febra C. COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis. Ann Epidemiol. 2021;57:14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7920817</ArticleId><ArticleId IdType="pubmed">33662494</ArticleId></ArticleIdList></Reference><Reference><Citation>Long H, Nie L, Xiang X, Li H, Zhang X, Fu X, et al. D-Dimer and prothrombin time are the significant indicators of severe COVID-19 and poor prognosis. Biomed Res Int. 2020;2020:6159720. 10.1155/2020/6159720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301188</ArticleId><ArticleId IdType="pubmed">32596339</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Ye J, Chen Q, Hu W, Wang L, Fan Y, et al. Elevated Lactate Dehydrogenase level as an independent risk factor for the severity and mortality of COVID-19. Aging (Albany NY). 2020;12:15670. 10.18632/AGING.103770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7467395</ArticleId><ArticleId IdType="pubmed">32805722</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagyas M, Fejes Z, Sütő R, Nagy Z, Székely B, Pócsi M, et al. Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients. Int J Infect Dis. 2022. 10.1016/j.ijid.2021.11.028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8613979</ArticleId><ArticleId IdType="pubmed">34838959</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W, Yao J, Chen A, Lv Q, Zanin M, Liu J, et al. Early triage of critically ill COVID-19 patients using deep learning. Nat Commun. 2020;11:3543. 10.1038/s41467-020-17280-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7363899</ArticleId><ArticleId IdType="pubmed">32669540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E, et al. Prediction models for diagnosis and prognosis of covid-19: Systematic review and critical appraisal. BMJ. 2020;369:m1328. 10.1136/bmj.m1328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7222643</ArticleId><ArticleId IdType="pubmed">32265220</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Liang W, Jiang M, Guan W, Zhan C, Wang T, et al. Risk factors of fatal outcome in hospitalized subjects with Coronavirus disease 2019 from a nationwide analysis in China. Chest. 2020;158:97. 10.1016/j.chest.2020.04.010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158802</ArticleId><ArticleId IdType="pubmed">32304772</ArticleId></ArticleIdList></Reference><Reference><Citation>Andargie TE, Tsuji N, Seifuddin F, Jang MK, Yuen PST, Kong H, et al. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury. JCI Insight. 2021;6:e147610. 10.1172/jci.insight.147610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8119224</ArticleId><ArticleId IdType="pubmed">33651717</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng AP, Cheng MP, Gu W, Sesing Lenz J, Hsu E, Schurr E, et al. Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severity. Med. 2021;2:411-422.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836424</ArticleId><ArticleId IdType="pubmed">33521749</ArticleId></ArticleIdList></Reference><Reference><Citation>Scozzi D, Cano M, Ma L, Zhou D, Zhu JH, O’Halloran JA, et al. Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI Insight. 2021;6:1–16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934921</ArticleId><ArticleId IdType="pubmed">33444289</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Wu T, Li L, Lin Y, Ma Z, Xu J, et al. Transcriptional start site coverage analysis in plasma cell-free DNA reveals disease severity and tissue specificity of COVID-19 patients. Front Genet. 2021;12:663098. 10.3389/fgene.2021.663098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8194351</ArticleId><ArticleId IdType="pubmed">34122515</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y, Zheng F, Zhang T, Luo Q, Luo Y, Zhou R, et al. Integrating plasma cell-free DNA with clinical laboratory results enhances the prediction of critically ill patients with COVID-19 at hospital admission. Clin Transl Med. 2022;12:1–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9286531</ArticleId><ArticleId IdType="pubmed">35839327</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Zhou Y, Chen Y, Gu J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6129281</ArticleId><ArticleId IdType="pubmed">30423086</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H. Minimap2: Pairwise alignment for nucleotide sequences. Bioinformatics. 2018;34:3094. 10.1093/bioinformatics/bty191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6137996</ArticleId><ArticleId IdType="pubmed">29750242</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P, Sun K, Peng W, Cheng SH, Ni M, Yeung PC, et al. Plasma DNA end-motif profiling as a fragmentomic marker in cancer, pregnancy, and transplantation. Cancer Discov. 2020;10:664–73.</Citation><ArticleIdList><ArticleId IdType="pubmed">32111602</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei P-F. Diagnosis and treatment protocol for novel coronavirus pneumonia (Trial version 7). Chin Med J. 2020;133:1087–95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7213636</ArticleId><ArticleId IdType="pubmed">32358325</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo YMD, Han DSC, Jiang P, Chiu RWK. Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies. Science (80- ). 2021;372:eaaw3616.</Citation><ArticleIdList><ArticleId IdType="pubmed">33833097</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez C, Roch B, Mazard T, Blache P, Al Amir Dache Z, Pastor B, et al. Circulating nuclear DNA structural features, origins, and complete size profile revealed by fragmentomics. JCI Insight. 2021;6:e144561. 10.1172/jci.insight.144561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8119211</ArticleId><ArticleId IdType="pubmed">33571170</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X, Wang Y, Xu J, Li Y, Cheng F, Luo Y, et al. Plasma cell-free DNA promise disease monitoring and tissue injury assessment of COVID-19. medRxiv. 2021;298:823.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10104435</ArticleId><ArticleId IdType="pubmed">37059908</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun K, Jiang P, Wong AIC, Cheng YKY, Cheng SH, Zhang H, et al. Size-tagged preferred ends in maternal plasma DNA shed light on the production mechanism and show utility in noninvasive prenatal testing. Proc Natl Acad Sci U S A. 2018;115:E5106. 10.1073/pnas.1804134115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5984542</ArticleId><ArticleId IdType="pubmed">29760053</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P, Sun K, Tong YK, Cheng SH, Cheng THTT, Heung MMSS, et al. Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma. Proc Natl Acad Sci U S A. 2018;115:E10925–33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6243268</ArticleId><ArticleId IdType="pubmed">30373822</ArticleId></ArticleIdList></Reference><Reference><Citation>Han DSC, Ni M, Chan RWY, Chan VWH, Lui KO, Chiu RWK, et al. The biology of cell-free DNA fragmentation and the roles of DNASE1, DNASE1L3, and DFFB. Am J Hum Genet. 2020;106:202. 10.1016/j.ajhg.2020.01.008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7010979</ArticleId><ArticleId IdType="pubmed">32004449</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulz P, Thallinger GG, Auer M, Graf R, Kashofer K, Jahn SW, et al. Inferring expressed genes by whole-genome sequencing of plasma DNA. Nat Genet. 2016;48:1273–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">27571261</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6447622</ArticleId><ArticleId IdType="pubmed">30944313</ArticleId></ArticleIdList></Reference><Reference><Citation>Thierry AR, Roch B. Neutrophil extracellular traps and by-products play a key role in COVID-19: pathogenesis, risk factors, and therapy. J Clin Med. 2020;9:2942. 10.3390/jcm9092942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7565044</ArticleId><ArticleId IdType="pubmed">32933031</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med. 2020;217:e20200652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7161085</ArticleId><ArticleId IdType="pubmed">32302401</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5:e138999. 10.1172/jci.insight.138999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308057</ArticleId><ArticleId IdType="pubmed">32329756</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma MJL, Zhang H, Jiang P, Sin STK, Lam WKJ, Cheng SH, et al. Topologic analysis of plasma mitochondrial DNA reveals the coexistence of both linear and circular molecules. Clin Chem. 2019;65:1161–70.</Citation><ArticleIdList><ArticleId IdType="pubmed">31263037</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Guo X, Guo S, Wang Y, Chen L, Liu Y, et al. Next generation sequencing-based analysis of mitochondrial DNA characteristics in plasma extracellular vesicles of patients with hepatocellular carcinoma. Oncol Lett. 2020;20:2820. 10.3892/ol.2020.11831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7400774</ArticleId><ArticleId IdType="pubmed">32782600</ArticleId></ArticleIdList></Reference><Reference><Citation>Korabecna M, Zinkova A, Brynychova I, Chylikova B, Prikryl P, Sedova L, et al. Cell-free DNA in plasma as an essential immune system regulator. Sci Rep. 2020;10:17478. 10.1038/s41598-020-74288-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7566599</ArticleId><ArticleId IdType="pubmed">33060738</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschini E, Cozzi-Lepri A, Santoro A, Bacca E, Lancellotti G, Menozzi M, et al. Herpes simplex virus re-activation in patients with SARS-CoV-2 pneumonia: A prospective, observational study. Microorganisms. 2021;9:1896. 10.3390/microorganisms9091896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8465957</ArticleId><ArticleId IdType="pubmed">34576791</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer A, Buetti N, Houhou-Fidouh N, Patrier J, Abdel-Nabey M, Jaquet P, et al. HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients. Crit Care. 2021;25:417. 10.1186/s13054-021-03843-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8647503</ArticleId><ArticleId IdType="pubmed">34872611</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanshal M, Ahmed HS. COVID-19 and herpes simplex virus infection: a cross-sectional study. Cureus. 2021;13:e18022. 10.7759/cureus.18022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8520410</ArticleId><ArticleId IdType="pubmed">34667693</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigón L, García-Pérez J, Rodríguez-Mora S, Torres M, Mateos E, Castillo de la Osa M, et al. Impaired antibody-dependent cellular cytotoxicity in a Spanish cohort of patients with COVID-19 admitted to the ICU. Front Immunol. 2021;12:742631. 10.3389/fimmu.2021.742631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8488389</ArticleId><ArticleId IdType="pubmed">34616404</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhaddou M, Memon D, Meyer B, White KM, Rezelj VV, Correa Marrero M, et al. The Global phosphorylation landscape of SARS-CoV-2 infection. Cell. 2020;182:685. 10.1016/j.cell.2020.06.034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7321036</ArticleId><ArticleId IdType="pubmed">32645325</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JY, Zhang W, Roehrl MW, Roehrl VB, Roehrl MH. An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19. J Autoimmun. 2021;120:102644. 10.1016/j.jaut.2021.102644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075847</ArticleId><ArticleId IdType="pubmed">33971585</ArticleId></ArticleIdList></Reference><Reference><Citation>Young BE, Ong SWX, Ng LFP, Anderson DE, Chia WN, Chia PY, et al. Viral dynamics and immune correlates of coronavirus disease 2019 (COVID-19) severity. Clin Infect Dis. 2021;73:e2932.10.1093/cid/ciaa1280</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499509</ArticleId><ArticleId IdType="pubmed">32856707</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Chen D, Hou J, Li H, Cao D, Guo M, et al. An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis. Cytokine. 2021;138:155365. 10.1016/j.cyto.2020.155365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7651249</ArticleId><ArticleId IdType="pubmed">33246770</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020;323:1239–42.</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>